| scholarly article | Q13442814 |
| P50 | author | Mostafa Elhodaky | Q57656739 |
| P2093 | author name string | Julie E Lang | |
| Victoria A Forte | |||
| Anson Snow | |||
| Lily Tung | |||
| Dany K Barrak | |||
| P2860 | cites work | Initial sequencing and analysis of the human genome | Q21045365 |
| DNA sequencing with chain-terminating inhibitors | Q22066207 | ||
| Finishing the euchromatic sequence of the human genome | Q22122488 | ||
| Genome sequencing in microfabricated high-density picolitre reactors | Q24544260 | ||
| Isolation of rare circulating tumour cells in cancer patients by microchip technology | Q24597164 | ||
| Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay | Q24608051 | ||
| Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers | Q24614672 | ||
| RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis | Q24626854 | ||
| Circulating tumor cells: approaches to isolation and characterization | Q24631347 | ||
| High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis | Q24634121 | ||
| Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS) | Q24635921 | ||
| MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype | Q24646090 | ||
| Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance | Q24646761 | ||
| A large genome center's improvements to the Illumina sequencing system | Q24656090 | ||
| Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis | Q24798477 | ||
| Emerging technologies for CTC detection based on depletion of normal cells | Q27009519 | ||
| Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities | Q27345462 | ||
| Inhibition of Mutated, Activated BRAF in Metastatic Melanoma | Q27860458 | ||
| Sequencing technologies - the next generation | Q27860568 | ||
| Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 | ||
| Molecular portraits of human breast tumours | Q28032461 | ||
| Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis | Q28131703 | ||
| Double-stranded DNA in exosomes: a novel biomarker in cancer detection | Q28237711 | ||
| Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays | Q28263829 | ||
| Accurate multiplex polony sequencing of an evolved bacterial genome | Q28265850 | ||
| A sequencing method based on real-time pyrophosphate | Q28279786 | ||
| Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis | Q28283104 | ||
| Next-generation DNA sequencing methods | Q28285066 | ||
| Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases | Q28289395 | ||
| FISH-based determination of HER2 status in circulating tumor cells isolated with the microfluidic CEE™ platform. | Q54540577 | ||
| Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. | Q54769141 | ||
| Free DNA in the serum of cancer patients and the effect of therapy. | Q55492005 | ||
| Cell-Free Plasma DNA during Peritoneal Dialysis and Hemodialysis and in Patients with Chronic Kidney Disease | Q57557797 | ||
| K-ras point mutation detection in lung cancer: comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification | Q58068714 | ||
| External quality assurance of circulating tumor cell enumeration using the CellSearch® system: A feasibility study | Q58282445 | ||
| Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques | Q72553950 | ||
| Effects of blood-processing protocols on cell-free DNA quantification in plasma | Q73036135 | ||
| Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cells | Q73207838 | ||
| Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer | Q73469713 | ||
| Detection of circulating tumor cells in blood using an optimized density gradient centrifugation | Q73487731 | ||
| The cytologic demonstration and significance of tumor cells in the mesenteric venous blood in patients with colorectal carcinoma | Q73739804 | ||
| P53 mutations in primary and metastatic tumors and circulating tumor cells from colorectal carcinoma patients | Q74352266 | ||
| Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients | Q77372876 | ||
| Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood | Q78582458 | ||
| The clinical significance of circulating tumor cells | Q79680217 | ||
| The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients | Q80531692 | ||
| Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer | Q81199589 | ||
| Circulating tumor cells in patients with breast cancer dormancy | Q81208525 | ||
| Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer | Q81483516 | ||
| Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples | Q81511462 | ||
| Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients | Q82847059 | ||
| Analysis of loss of heterozygosity in circulating DNA | Q83694195 | ||
| High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients | Q84277674 | ||
| Circulating tumor cells: getting more from less | Q84524811 | ||
| Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice | Q84719462 | ||
| Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas | Q85049473 | ||
| Targeting Mutant AKT in Cancer | Q86715259 | ||
| Analysis of next-generation genomic data in cancer: accomplishments and challenges | Q28293359 | ||
| The origin of the Haitian cholera outbreak strain | Q28300132 | ||
| Real-time DNA sequencing from single polymerase molecules | Q28301519 | ||
| Product differentiation by analysis of DNA melting curves during the polymerase chain reaction | Q28305051 | ||
| Tumour evolution inferred by single-cell sequencing | Q28646966 | ||
| Molecular biomarker analyses using circulating tumor cells | Q28749394 | ||
| Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification Reactions | Q29395822 | ||
| The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited | Q29547915 | ||
| Analysis of circulating tumor DNA to monitor metastatic breast cancer | Q29614797 | ||
| Detection of mutations in EGFR in circulating lung-cancer cells | Q29615033 | ||
| Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition | Q29615853 | ||
| Real time quantitative PCR | Q29616373 | ||
| Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET | Q29618139 | ||
| Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA | Q29620083 | ||
| In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. | Q30454393 | ||
| In vivo, noninvasive, label-free detection and eradication of circulating metastatic melanoma cells using two-color photoacoustic flow cytometry with a diode laser | Q30479108 | ||
| A simple biological imaging system for detecting viable human circulating tumor cells | Q30490534 | ||
| Isolation of circulating tumor cells using a microvortex-generating herringbone-chip | Q30497257 | ||
| Isolation and retrieval of circulating tumor cells using centrifugal forces. | Q30535350 | ||
| Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data | Q30779447 | ||
| Detection of circulating melanoma cells in human blood using photoacoustic flowmetry | Q30958715 | ||
| A rare-cell detector for cancer | Q31092483 | ||
| Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection | Q33245050 | ||
| Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse | Q33322711 | ||
| Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope | Q33358010 | ||
| A comparison of RNA amplification techniques at sub-nanogram input concentration | Q33484382 | ||
| Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model | Q33507492 | ||
| Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146. | Q33551239 | ||
| An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. | Q33590850 | ||
| Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. | Q33663019 | ||
| Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer | Q33667666 | ||
| Confocal images of circulating tumor cells obtained using a methodology and technology that removes normal cells | Q33691179 | ||
| PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer | Q33715936 | ||
| Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients. | Q33762644 | ||
| Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients | Q33857819 | ||
| Circulating tumor cells predict survival in early average-to-high risk breast cancer patients | Q33958981 | ||
| Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology | Q35584856 | ||
| The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy. | Q35681975 | ||
| Genomic analysis of circulating cell-free DNA infers breast cancer dormancy | Q35694373 | ||
| Circulating breast cancer cells are frequently apoptotic | Q35746628 | ||
| Sensitive sequencing method for KRAS mutation detection by Pyrosequencing | Q35789986 | ||
| Single-Molecule Sequencing Reveals Estrogen-Regulated Clinically Relevant lncRNAs in Breast Cancer. | Q35795043 | ||
| The CTC-chip: an exciting new tool to detect circulating tumor cells in lung cancer patients | Q35800375 | ||
| A microfluidic device for label-free, physical capture of circulating tumor cell clusters | Q35812039 | ||
| MicroRNAs in apoptosis, autophagy and necroptosis | Q35832148 | ||
| Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients | Q35955325 | ||
| Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. | Q36071451 | ||
| Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA. | Q36145554 | ||
| Pyrosequencing: history, biochemistry and future | Q36258365 | ||
| A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma | Q36437111 | ||
| Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer | Q36544757 | ||
| High-resolution array comparative genomic hybridization of single micrometastatic tumor cells. | Q36633194 | ||
| Interactive analysis and assessment of single-cell copy-number variations | Q36642284 | ||
| Circulating nucleic acids (CNAs) and cancer--a survey | Q36669780 | ||
| Tumour exosome integrins determine organotropic metastasis. | Q36677568 | ||
| EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low | Q36689065 | ||
| Pyrosequencing applications | Q36690952 | ||
| Organotropism of breast cancer metastasis | Q36848841 | ||
| Tumor cell dissemination: emerging biological insights from animal models and cancer patients | Q36887350 | ||
| Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study | Q36924426 | ||
| Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients | Q36955133 | ||
| Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application? | Q36974719 | ||
| Pyrosequencing for discovery and analysis of DNA sequence variations | Q36989849 | ||
| Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. | Q37090760 | ||
| Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device | Q37104899 | ||
| Detection, clinical relevance and specific biological properties of disseminating tumour cells | Q37135356 | ||
| Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. | Q37140168 | ||
| Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer. | Q37206520 | ||
| Quantitative RT-PCR detection of colorectal tumor cells in peripheral blood--a systematic review | Q37214063 | ||
| Circulating tumor cells and bone marrow micrometastasis | Q37242269 | ||
| 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood | Q37259934 | ||
| Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer | Q37277185 | ||
| Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells | Q37360230 | ||
| Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer | Q37468681 | ||
| Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients | Q37480512 | ||
| Exosomes: proteomic insights and diagnostic potential | Q37505058 | ||
| Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes | Q37507435 | ||
| Genetic prognostic and predictive markers in colorectal cancer | Q37523207 | ||
| Circulating tumor cells: clinically relevant molecular access based on a novel CTC flow cell | Q37529377 | ||
| Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells | Q37531679 | ||
| Circulating and disseminated tumor cells in the management of breast cancer | Q37552483 | ||
| Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip | Q37569045 | ||
| Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches. | Q37605872 | ||
| Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring | Q37618897 | ||
| Recent advances in the molecular characterization of circulating tumor cells | Q37693504 | ||
| Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer | Q37721802 | ||
| Epithelial-to-mesenchymal transitions and circulating tumor cells | Q37744737 | ||
| Treatment of non-small-cell lung cancer with erlotinib or gefitinib | Q37851148 | ||
| Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology | Q37886990 | ||
| Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications | Q37894736 | ||
| Circulating tumor cells and circulating tumor DNA. | Q37952771 | ||
| Plasticity of disseminating cancer cells in patients with epithelial malignancies | Q38021683 | ||
| Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. | Q38037294 | ||
| Circulating tumor cells and DNA as liquid biopsies. | Q38133673 | ||
| Real-time liquid biopsy in cancer patients: fact or fiction? | Q38154437 | ||
| Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes | Q38273567 | ||
| SSA-MOA: a novel CTC isolation platform using selective size amplification (SSA) and a multi-obstacle architecture (MOA) filter | Q38461768 | ||
| Is the NCI MATCH trial a match for gynecologic oncology? | Q38639549 | ||
| Frequent expression of PD-L1 on circulating breast cancer cells | Q38861829 | ||
| Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients | Q38925555 | ||
| Apoptotic circulating tumor cells in early and metastatic breast cancer patients | Q39137881 | ||
| M30 neoepitope expression in epithelial cancer: quantification of apoptosis in circulating tumor cells by CellSearch analysis. | Q39639547 | ||
| A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter | Q39675091 | ||
| Application of a filtration- and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma | Q39695115 | ||
| Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients | Q39734908 | ||
| A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. | Q39751877 | ||
| Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells | Q40121443 | ||
| Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood | Q40186258 | ||
| Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancer. | Q40280975 | ||
| Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry | Q40438772 | ||
| Whole-genome bisulfite sequencing of cell-free DNA identifies signature associated with metastatic breast cancer. | Q40528885 | ||
| Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells | Q40830360 | ||
| Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry | Q41306536 | ||
| Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program | Q41382683 | ||
| Nucleic acid-based methods for the detection of cancer | Q41628883 | ||
| Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction | Q41656564 | ||
| Feasibility study of red blood cell debulking by magnetic field-flow fractionation with step-programmed flow. | Q42001928 | ||
| Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine | Q42882313 | ||
| DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. | Q43540280 | ||
| Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing | Q46302330 | ||
| Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing | Q47163678 | ||
| Meta-analysis of the prognostic value of circulating tumor cells in breast cancer | Q47240978 | ||
| Effects of preanalytical factors on the molecular size of cell-free DNA in blood | Q47391984 | ||
| Pyrophosphorolysis-activated polymerization (PAP): application to allele-specific amplification | Q47585367 | ||
| Circulating tumour cells in non-metastatic breast cancer: a prospective study | Q47652073 | ||
| Man-made cell-like compartments for molecular evolution | Q47857062 | ||
| Case study of the morphologic variation of circulating tumor cells. | Q51091573 | ||
| BEAMing up for detection and quantification of rare sequence variants. | Q51283236 | ||
| Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. | Q51507853 | ||
| Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer. | Q51630365 | ||
| Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer. | Q51744140 | ||
| Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. | Q53314502 | ||
| Leaving home early: reexamination of the canonical models of tumor progression. | Q53317126 | ||
| Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. | Q53479490 | ||
| Microdevice for the isolation and enumeration of cancer cells from blood. | Q53510889 | ||
| Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing. | Q54239061 | ||
| Genomes for all. | Q33993431 | ||
| Tracing the tumor lineage | Q33998432 | ||
| High fragmentation characterizes tumour-derived circulating DNA. | Q34016528 | ||
| About the possible origin and mechanism of circulating DNA apoptosis and active DNA release | Q34100424 | ||
| Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis | Q34111187 | ||
| CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes | Q34112732 | ||
| Cell-free nucleic acids as biomarkers in cancer patients | Q34184393 | ||
| Landscape of next-generation sequencing technologies. | Q34187217 | ||
| Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification | Q34277946 | ||
| Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. | Q34278191 | ||
| Alta-Cyclic: a self-optimizing base caller for next-generation sequencing | Q34299405 | ||
| NanoVelcro Chip for CTC enumeration in prostate cancer patients | Q34354738 | ||
| The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy. | Q34373936 | ||
| Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500 | Q34402487 | ||
| Circulating tumor DNA as a liquid biopsy for cancer | Q34447436 | ||
| A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening | Q34492755 | ||
| Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer | Q34500359 | ||
| KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue | Q34509268 | ||
| MiR-27 as a prognostic marker for breast cancer progression and patient survival | Q34512567 | ||
| Molecular profiling of single circulating tumor cells with diagnostic intention | Q34542660 | ||
| Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression | Q34655105 | ||
| Cellular image analysis and imaging by flow cytometry | Q34656668 | ||
| The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method | Q34722580 | ||
| Transitions between epithelial and mesenchymal states in development and disease | Q34761972 | ||
| Is there a role for circulating tumor cells in the management of breast cancer? | Q34786955 | ||
| Cancer micrometastases | Q34978121 | ||
| Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy. | Q35000713 | ||
| Influence of plasma processing on recovery and analysis of circulating nucleic acids | Q35035846 | ||
| Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. | Q35174681 | ||
| Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment | Q35227986 | ||
| Insight into the heterogeneity of breast cancer through next-generation sequencing | Q35370090 | ||
| Enhanced ratio of signals enables digital mutation scanning for rare allele detection | Q35543098 | ||
| Future medical applications of single-cell sequencing in cancer | Q35558519 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 19-40 | |
| P577 | publication date | 2016-03-01 | |
| P1433 | published in | Cancer Biology & Medicine | Q26841841 |
| P1476 | title | The potential for liquid biopsies in the precision medical treatment of breast cancer | |
| P478 | volume | 13 |
| Q57474043 | ASO Author Reflections: The Whole Transcriptome Landscape of Circulating Tumor Cells in Nonmetastatic Breast Cancer |
| Q55078140 | Challenges in using liquid biopsies for gene expression profiling. |
| Q55053015 | Changes of KEAP1/NRF2 and IKB/NF-κB Expression Levels Induced by Cell-Free DNA in Different Cell Types. |
| Q28067549 | Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack |
| Q40971199 | Expression of guanylyl cyclase C in tissue samples and the circulation of rectal cancer patients |
| Q38621053 | Molecular characterization and heterogeneity of circulating tumor cells in breast cancer. |
| Q57490805 | SIRT1 and Estrogen Signaling Cooperation for Breast Cancer Onset and Progression |
Search more.